![]() |
市場調查報告書
商品編碼
1587597
到 2030 年分子量標記市場預測:按類型、交付方法、包裝、技術、應用和地區進行的全球分析Molecular Weight Marker Market Forecasts to 2030 - Global Analysis By Type (Protein Markers, DNA/RNA Markers, Peptide Markers, Nucleic Acid Markers and Other Types), Delivery Method, Packaging, Technology, Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球分子量標記市場規模為 9.8 億美元,預計到 2030 年將達到 24.2 億美元,預測期內複合年成長率為 15.2%。
分子量標記,也稱為蛋白質或 DNA 梯子,是一組包含凝膠電泳中使用的已知大小分子的標準品。它可作為透過比較未知蛋白質、核酸和其他生物分子在凝膠基質中的遷移來估計其分子量的參考。標記由與特定分子量相對應的條帶組成,從而可以精確地確定樣品分子的大小。該工具在分子生物學中至關重要,可在實驗過程中確認生物分子的身份、純度和大小。
根據 PLOS One Journal 2022 年 8 月發表的一篇論文,澳洲新南威爾斯州政府在 10 年內撥款 1.19 億美元用於 RNA 研究和開發,以支持一系列研究計劃。
越來越重視診斷和個人化醫療
個人化醫療需要對遺傳物質和蛋白質進行精確分析,以便為每個人量身定做治療方案,並且在很大程度上依賴於確定生物分子大小的分子量標記。此外,分子診斷學的進步,例如識別疾病生物標記和開發標靶治療,需要強大的蛋白質和 DNA 分析工具。這一趨勢正在加速分子量標記在基因組學、蛋白質組學和臨床實驗室中的採用,推動市場擴張。
缺乏基礎設施和技術專長
正確使用分子量標記需要專門的工具,例如電泳系統和分子生物學技術的專業知識。基礎設施和技術專長的缺乏是由於無法獲得先進的實驗室設備和技術人員所造成的。在生技部門不發達、研究經費有限和基礎設施陳舊的地區,缺乏這些必要資源會降低分子量標記的採用。這些地區限制了研究能力、減緩了市場成長並限制了全球擴張。
蛋白質體學和基因組學研究進展
蛋白質體學研究蛋白質的結構、功能和相互作用,並需要分子量標記來在電泳過程中準確評估蛋白質大小和純度。同樣,專注於 DNA 和 RNA序列測定和分析的基因組學研究依靠這些標記來確定各種實驗中核酸的大小。次世代定序和質譜等新技術的持續開拓,進一步增加了對高品質分子量標記的需求,並支持研發和生物技術領域的市場擴張。
先進標記的高成本
先進分子量標記物的高成本源於複雜的製造流程、嚴格的品管措施以及需要專門的材料來確保準確性和可靠性。此外,高成本可能會阻礙對重要研發計劃的投資,最終減緩該領域的創新。因此,經濟障礙是市場成長的主要阻礙因素,阻止許多潛在使用者在分子生物學應用中利用這些重要工具。
COVID-19 的影響
由於診斷、疫苗和治療開發方面的研究需求增加,COVID-19 大流行對分子量標記物市場產生了重大影響。實驗室和生物技術公司加速了分子生物學實驗,包括蛋白質和核酸分析,以了解病毒並開發治療方法。然而,供應鏈中斷以及製造和分銷限制造成了暫時的挫折。疫情過後,由於醫療保健、診斷和生物技術領域的持續研究,市場穩步復甦並實現持續成長。
毛細管電泳領域預計在預測期內規模最大
預計毛細管電泳細分市場將在整個預測期內佔據最大的市場佔有率。分子量標記分析中的毛細管電泳技術可根據大小和電荷以高解析度分離蛋白質和核酸等生物分子。此方法效率高、樣本量少、分析準確、快速,廣泛應用於基因體學、蛋白質體學和臨床診斷。
預計製藥領域在預測期內複合年成長率最高
預計製藥公司領域在預測期內的複合年成長率最高。在製藥公司中,分子量標記在藥物開發和品管過程中發揮重要作用。分子量標記用於在研究和製造過程中測量蛋白質、核酸和其他生物分子的大小和純度。分子量標記有助於分析藥物的分子結構,確保配方的一致性和準確性。
在生物技術、醫藥研究和學術機構投資不斷增加的推動下,亞太地區預計將在預測期內創下最大的市場佔有率。中國、印度和日本等國家是主要貢獻者,增加了基因研究、診斷和藥物發現領域對分子生物學工具的需求。不斷擴大的醫療基礎設施、政府舉措以及眾多生物技術公司的存在正在推動該地區的市場擴張。
由於生物技術和製藥領域的先進研究活動,預計北美在預測期內的複合年成長率最高。美國和加拿大是主要參與者,受益於學術機構、研究中心和生物技術公司的強大存在。該地區對個人化醫療、基因組學和蛋白質組學的關注繼續推動對各種應用的分子量標記的需求,部分原因是對診斷工具的需求不斷成長。
According to Stratistics MRC, the Global Molecular Weight Marker Market is accounted for $0.98 billion in 2024 and is expected to reach $2.42 billion by 2030 growing at a CAGR of 15.2% during the forecast period. A molecular weight marker, also known as a protein or DNA ladder, is a set of standards containing molecules of known sizes used in gel electrophoresis. It serves as a reference to estimate the molecular weight of unknown proteins, nucleic acids, or other biomolecules by comparing their migration through a gel matrix. The marker consists of bands corresponding to specific molecular weights, enabling precise determination of the sizes of sample molecules. This tool is essential in molecular biology for confirming the identity, purity, and size of biomolecules during experiments.
According to an article published by PLOS One Journal in August 2022, the government of New South Wales in Australia allocated USD 119 million over 10 years to RNA R&D to support a pipeline of research projects.
Increased focus on diagnostics and personalized medicine
Personalized medicine requires precise analysis of genetic material and proteins to tailor treatments for individuals, relying heavily on molecular weight markers for size determination of biomolecules. Additionally, advancements in molecular diagnostics, such as the identification of disease biomarkers and development of targeted therapies, necessitate robust tools for protein and DNA analysis. This trend accelerates the adoption of molecular weight markers in genomics, proteomics, and clinical laboratories, fueling market expansion.
Lack of infrastructure and technical expertise
Proper use of molecular weight markers requires specialized tools like electrophoresis systems and expertise in molecular biology techniques. Lack of infrastructure and technical expertise stems from insufficient access to advanced laboratory equipment and skilled personnel. In regions with underdeveloped biotech sectors, limited research funding, and outdated infrastructure, these essential resources are scarce, leading to reduced adoption of molecular weight markers. This restricts research capacity and slows the growth of the market in such regions, limiting its global expansion.
Advancements in proteomics and genomics research
In proteomics, studying the structure, function, and interactions of proteins requires molecular weight markers for accurate protein sizing and purity assessments during electrophoresis. Similarly, genomics research, which focuses on DNA and RNA sequencing and analysis, relies on these markers to determine nucleic acid sizes in various experiments. The continuous development of new techniques, such as next-generation sequencing and mass spectrometry, further amplifies the need for high-quality molecular weight markers, propelling market expansion in research and biotechnology sectors.
High costs of advanced markers
High costs of advanced molecular weight markers arise from the complex manufacturing processes, stringent quality control measures, and the need for specialized materials to ensure accuracy and reliability. Additionally, high costs may deter investment in essential research and development projects, ultimately slowing down innovation in the field. As a result, the financial barrier poses a significant restraint on market growth, preventing many potential users from utilizing these vital tools in their molecular biology applications.
Covid-19 Impact
The covid-19 pandemic significantly impacted the molecular weight marker market, driven by increased demand for research in diagnostics, vaccines, and therapeutic development. Laboratories and biotech firms accelerated molecular biology experiments, such as protein and nucleic acid analysis, to understand the virus and develop treatments. However, supply chain disruptions and restrictions in manufacturing and distribution caused temporary setbacks. Post-pandemic, the market saw steady recovery, with sustained growth due to ongoing research in healthcare, diagnostics, and biotechnology sectors.
The capillary electrophoresis segment is expected to be the largest during the forecast period
The capillary electrophoresis segment is predicted to secure the largest market share throughout the forecast period. Capillary electrophoresis technology in molecular weight marker analysis offers high-resolution separation of biomolecules, such as proteins and nucleic acids, based on size and charge. This method is highly efficient, requiring minimal sample quantities, offering rapid analysis with greater accuracy, and is widely used in genomics, proteomics, and clinical diagnostics.
The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period
The pharmaceutical companies segment is anticipated to witness the highest CAGR during the forecast period. In pharmaceutical companies, molecular weight markers play a crucial role in drug development and quality control processes. They are used to determine the size and purity of proteins, nucleic acids, and other biomolecules during research and production. Molecular weight markers aid in analyzing the molecular structure of drugs, ensuring consistency and accuracy in formulations.
Asia Pacific is expected to register the largest market share during the forecast period driven by rising investments in biotechnology, pharmaceutical research, and academic institutions. Countries like China, India, and Japan are key contributors, with increasing demand for molecular biology tools in genetic research, diagnostics, and drug discovery. Expanding healthcare infrastructure, government initiatives and the presence of numerous biotechnology companies are fueling market expansion in the region.
North America is projected to witness the highest CAGR over the forecast period fuelled by advanced research activities in biotechnology and pharmaceuticals. The United States and Canada are key players, benefiting from a strong presence of academic institutions, research centers, and biotech companies. The region's focus on personalized medicine, genomics, and proteomics, along with the rise in demand for diagnostic tools, continues to bolster the demand for molecular weight markers across various applications.
Key players in the market
Some of the key players profiled in the Molecular Weight Marker Market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sigma-Aldrich, GE Healthcare, Fujifilm Corporation, Becton, Dickinson and Company (BD), PerkinElmer Inc., Agilent Technologies Inc., Roche Diagnostics, VWR International LLC, Abcam plc, Jena Bioscience GmbH, QIAGEN N.V., Amgen Inc., Santa Cruz Biotechnology Inc., Takara Bio Inc., New England Biolabs Inc. (NEB) and Promega Corporation.
In November 2023, Bio-Rad Laboratories launched a new range of molecular weight markers tailored for high-resolution gel electrophoresis. These markers meet the growing demand for precision in protein analysis, enhancing the accuracy of molecular weight estimation. This innovation supports scientists in achieving more accurate results, reinforcing Bio-Rad's commitment to advancing laboratory technologies.
In August 2023, Thermo Fisher Scientific introduced an upgraded line of prestained molecular weight markers designed to enhance visualization and accuracy in gel electrophoresis, which is crucial for advancements in proteomics research. These markers come in a range of molecular weights, accommodating sizes from as low as 10 kDa to as high as 250 kDa.
In May 2023, Agilent Technologies introduced a new synthetic RNA molecular weight marker designed to enhance RNA analysis workflows. This product specifically targets improvements in techniques like northern blotting, which are essential for studying RNA expression and function in various biological contexts.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.